6.
So F, Guthrie N, Chambers A, Moussa M, Carroll K
. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer. 1996; 26(2):167-81.
DOI: 10.1080/01635589609514473.
View
7.
Elmer G, Lafferty W, Tyree P, Lind B
. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother. 2007; 41(10):1617-24.
PMC: 2864004.
DOI: 10.1345/aph.1K221.
View
8.
Guthrie N, Carroll K
. Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol. 1998; 439:227-36.
DOI: 10.1007/978-1-4615-5335-9_16.
View
9.
Rodrigues A, Sandstrom A, Ca T, Steinsland H, Jensen H, Aaby P
. Protection from cholera by adding lime juice to food - results from community and laboratory studies in Guinea-Bissau, West Africa. Trop Med Int Health. 2000; 5(6):418-22.
DOI: 10.1046/j.1365-3156.2000.00575.x.
View
10.
Gharagozloo M, Ghaderi A
. Immunomodulatory effect of concentrated lime juice extract on activated human mononuclear cells. J Ethnopharmacol. 2001; 77(1):85-90.
DOI: 10.1016/s0378-8741(01)00269-0.
View
11.
Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W
. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res. 1998; 58(12):2550-6.
View
12.
Vincent J, HARRIS S, Foulds G, Dogolo L, Willavize S, Friedman H
. Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. Br J Clin Pharmacol. 2000; 50(5):455-63.
PMC: 2014412.
DOI: 10.1046/j.1365-2125.2000.00283.x.
View
13.
Murakami A, Nakamura Y, Ohto Y, Yano M, Koshiba T, Koshimizu K
. Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. Biofactors. 2001; 12(1-4):187-92.
DOI: 10.1002/biof.5520120130.
View
14.
Xu J, Go M, Lim L
. Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit, and pummelo. Pharm Res. 2003; 20(2):169-76.
DOI: 10.1023/a:1022254617664.
View
15.
Heck A, DeWitt B, Lukes A
. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000; 57(13):1221-7; quiz 1228-30.
View
16.
Gharagozloo M, Doroudchi M, Ghaderi A
. Effects of Citrus aurantifolia concentrated extract on the spontaneous proliferation of MDA-MB-453 and RPMI-8866 tumor cell lines. Phytomedicine. 2002; 9(5):475-7.
DOI: 10.1078/09447110260571751.
View
17.
Schmidt E, Remberg G, Knackmuss H
. Chemical structure and biodegradability of halogenated aromatic compounds. Halogenated muconic acids as intermediates. Biochem J. 1980; 192(1):331-7.
PMC: 1162338.
DOI: 10.1042/bj1920331.
View
18.
Suvarna R, Pirmohamed M, Henderson L
. Possible interaction between warfarin and cranberry juice. BMJ. 2003; 327(7429):1454.
PMC: 300803.
DOI: 10.1136/bmj.327.7429.1454.
View
19.
Leung V, Shalansky S, Lo M, Jadusingh E
. Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin. Ann Pharmacother. 2009; 43(5):875-81.
DOI: 10.1345/aph.1L631.
View
20.
Rooprai H, Kandanearatchi A, Maidment S, Christidou M, Trillo-Pazos G, Dexter D
. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol Appl Neurobiol. 2001; 27(1):29-39.
DOI: 10.1046/j.0305-1846.2000.00298.x.
View